SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFC14A - Definitive proxy statement, contested solicitations:
SEC Accession No. 0001193125-17-092181
Filing Date
2017-03-22
Accepted
2017-03-22 16:55:07
Documents
3
Effectiveness Date
2017-03-22

Document Format Files

Seq Description Document Type Size
1 DEFC14A d344936ddefc14a.htm DEFC14A 178833
2 GRAPHIC g3449361.jpg GRAPHIC 136369
3 GRAPHIC g3449362.jpg GRAPHIC 139067
  Complete submission text file 0001193125-17-092181.txt   559925
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005 6502389600
Innoviva, Inc. (Subject) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFC14A | Act: 34 | File No.: 000-30319 | Film No.: 17707257
SIC: 2834 Pharmaceutical Preparations

Mailing Address 660 STEAMBOAT ROAD GREENWICH CT 06830
Business Address 660 STEAMBOAT ROAD GREENWICH CT 06830 203-302-2330
Sarissa Capital Management LP (Filed by) CIK: 0001577524 (see all company filings)

IRS No.: 900924432 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFC14A